{"id":"NCT01515345","sponsor":"Kaiser Franz Josef Hospital","briefTitle":"Individualizing Dual Antiplatelet Therapy After Percutaneous Coronary Intervention - The IDEAL-PCI Registry","officialTitle":"Individualizing Dual Antiplatelet Therapy After Percutaneous Coronary Intervention - The IDEAL-PCI Registry","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-07","primaryCompletion":"2013-01","completion":"2013-01","firstPosted":"2012-01-24","resultsPosted":"2013-05-01","lastUpdate":"2017-04-25"},"enrollment":1008,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Platelet Inhibition","Coronary Stent Implantation"],"interventions":[{"type":"DRUG","name":"prasugrel or ticagrelor","otherNames":["Efient","Brilique"]},{"type":"DRUG","name":"Clopidogrel","otherNames":["Plavix"]}],"arms":[{"label":"standard therapy","type":"ACTIVE_COMPARATOR"},{"label":"individualized therapy","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to determine the efficacy and safety of a routine individualized antiplatelet therapy after coronary stent implantation by evaluating \"on-treatment\" platelet reactivity with Multiple Electrode Aggregometry (MEA, MultiplateÂ® Analyzer).","primaryOutcome":{"measure":"Definite Stent Thrombosis","timeFrame":"30 days","effectByArm":[{"arm":"Standard Therapy","deltaMin":1,"sd":null},{"arm":"Individualized Therapy","deltaMin":0,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":1,"countries":["Austria"]},"refs":{"pmids":["19264241","18387444","21406646","25361837"],"seeAlso":["http://www.multiplate.net"]},"adverseEventsSummary":{"seriousAny":{"events":26,"n":664},"commonTop":[]}}